Gene · 4090
Papers3,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of Ishophloroglucin A Isolated from Ishige okamurae on In Vitro Osteoclastogenesis and Osteoblastogenesis. | Mar Drugs | 2023 | 37504908 | PubTator, text mining | PubMed |
| Tissue tension permits β-catenin phosphorylation to drive mesoderm specification in human embryonic stem cells. | bioRxiv | 2023 | 37503095 | PubTator, text mining | PubMed |
| It is worth the weight: obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma. | Blood Adv | 2023 | 37493975 | PubTator, text mining | PubMed |
| Emerging roles of circular RNAs in stem cells. | Genes Dis | 2023 | 37492713 | PubTator, text mining | PubMed |
| GDF-11 downregulates placental human chorionic gonadotropin expression by activating SMAD2/3 signaling. | Cell Commun Signal | 2023 | 37480123 | PubTator, text mining | PubMed |
| The effects of Gli1 and Gli2 on BMP9-induced osteogenic differentiation of mesenchymal stem cells. | Tissue Cell | 2023 | 37478645 | PubTator, text mining | PubMed |
| Exosome-mediated long noncoding RNA (lncRNA) PART1 suppresses malignant progression of oral squamous cell carcinoma via miR-17-5p/SOCS6 axis. | Turk J Med Sci | 2023 | 37476905 | PubTator, text mining | PubMed |
| Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges. | Mil Med Res | 2023 | 37460924 | PubTator, text mining | PubMed |
| Iron regulatory proteins: players or pawns in ferroptosis and cancer? | Front Mol Biosci | 2023 | 37457833 | PubTator, text mining | PubMed |
| Activin receptor-like kinase 3: a critical modulator of development and function of mineralized tissues. | Front Cell Dev Biol | 2023 | 37457289 | PubTator, text mining | PubMed |
| Bone Morphogenetic Protein 13 Has Protumorigenic Effects on Hepatocellular Carcinoma Cells In Vitro. | Int J Mol Sci | 2023 | 37446238 | PubTator, text mining | PubMed |
| The Microenvironment of the Pathogenesis of Cardiac Hypertrophy. | Cells | 2023 | 37443814 | PubTator, text mining | PubMed |
| BMP4 upregulates glycogen synthesis through the SMAD/SLC2A1 (GLUT1) signaling axis in hepatocellular carcinoma (HCC) cells. | Cancer Metab | 2023 | 37443106 | PubTator, text mining | PubMed |
| Integrated High-Throughput Bioinformatics (Microarray, RNA-Seq, and RNA Interaction) and qRT-PCR Investigation of BMPR1B Axis as a Potential Diagnostic Biomarker of Isfahan Breast Cancer. | Adv Biomed Res | 2023 | 37434942 | PubTator, text mining | PubMed |
| Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis. | Clin Cancer Res | 2023 | 37432984 | PubTator, text mining | PubMed |
| Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia. | Leukemia | 2023 | 37422594 | PubTator, text mining | PubMed |
| Nicotinamide adenine dinucleotide kinase promotes lymph node metastasis of NSCLC via activating ID1 expression through BMP pathway. | Int J Biol Sci | 2023 | 37416767 | PubTator, text mining | PubMed |
| Correction: Transmembrane anterior posterior transformation 1 regulates BMP signaling and modulates the protein stability of SMAD1/5. | J Biol Chem | 2023 | 37393648 | PubTator, text mining | PubMed |
| TGF-β Signaling in Progression of Oral Cancer. | Int J Mol Sci | 2023 | 37373414 | PubTator, text mining | PubMed |
| PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway. | Int J Mol Sci | 2023 | 37373155 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4090/papers?page=10